Results 21 to 30 of about 3,781,222 (303)
An Adjudication Protocol for Severe Pneumonia
Background Clinical end points that constitute successful treatment in severe pneumonia are difficult to ascertain and vulnerable to bias. The utility of a protocolized adjudication procedure to determine meaningful end points in severe pneumonia has not
Chiagozie I. Pickens +10 more
semanticscholar +1 more source
Background: The signs and symptoms of pneumonia are often nonspecificand widely vary based on the patient’s age and the infectious organisms involved. IMNCI hasimproved case improved diagnose of pneumonia. This study was conducted to study thefrequency of correctly diagnosed cases of severe pneumonia by IMNCI classification in childrenbetween 2 – 59 ...
Asim Amjad +2 more
openaire +3 more sources
Biomarkers of low-grade inflammation have been associated with susceptibility to a severe infectious disease course, even when measured prior to disease onset.
H. Julkunen +3 more
semanticscholar +1 more source
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Background Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Minimal data are available from adequately powered randomized, controlled
V. Simonovich +38 more
semanticscholar +1 more source
Viral reactivation is widespread in patients with severe pneumonia, yet the landscape of viral reactivation in the lungs is not well‐known. This study aims to assess the landscape and clinical features of viral reactivation in the early onset of severe ...
Ling-na Huang +12 more
semanticscholar +1 more source
Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia
Severe 2019 novel coronavirus infectious disease (COVID-19) with pneumonia is associated with high rates of admission to the intensive care unit (ICU). Bacterial coinfection has been reported to be rare.
Alexandre Elabbadi +5 more
semanticscholar +1 more source
Clinical Symptoms and Outcomes of Severe Pneumonia Caused by Chlamydia psittaci in Southwest China
Here, we aimed to retrospectively analyze the clinical characteristics of 27 patients with severe pneumonia caused by Chlamydia psittaci between January 2019 and April 2021 in southwest China.
Fuxun Yang +12 more
semanticscholar +1 more source
Background Psittacosis, which is also known as parrot fever, is Chlamydia psittaci (C. psittaci) caused infectious disease . The clinical manifestations vary from asymptomatic infection to severe atypical pneumonia or even fatal meningitis.
Yunfeng Shi +7 more
semanticscholar +1 more source
Background Critically ill patients frequently suffer from vitamin C deficiency. Previous studies showed that high doses of vitamin C administration had conflicting results on clinical outcomes in patients with severe sepsis, burns, and trauma. Because of
A. Mahmoodpoor +5 more
semanticscholar +1 more source
In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus pneumonia (NCP) cases were a concern.
N. Tang +3 more
semanticscholar +1 more source

